Does US FDA Need An Independent Commission To Analyze Its Pandemic Response?

Group of outside experts could help the agency determine the pandemic-inspired practices and regulatory changes to keep, former commissioner von Eschenbach says.

Screenshot from FDLI Annual Conference of former commissioners' discussion
Former FDA commissioners Andrew von Eschenbach, Robert Califf and Mark McClellan discuss how the pandemic changed the agency with FDLI President and CEO Amy Comstock Rick. • Source: Screenshot

More from Agency Leadership

More from Pink Sheet